JX-1395

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameJX-1395
Drug Alias Nameoncolytic vaccinia virus therapy expressing GM-CSF (Jennerex)GM-CSF-expressing vaccinia virus (Jennerex)JX-1395
ClassificationBiologics > Oncolytic virus
Mechanisms of ActionGranulocyte-macrophage colony-stimulating factor receptor stimulants
TargetsGranulocyte-macrophage colony-stimulating factor receptor
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesJennerex Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesJennerex Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A